Shares of Health Care sector company Johnson & Johnson moved -0.4% today, and are now trading at a price of $158.24. The large-cap stock's daily volume was 4,091,408 compared to its average volume of 6,870,442. The S&P 500 index returned a -0.0% performance.
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company is based in New Brunswick and has 152,700 full time employees. Its market capitalization is $380,928,032,768. Johnson & Johnson currently offers its equity investors a dividend that yields 2.9% per year.
21 analysts are following Johnson & Johnson and have set target prices ranging from $155.0 to $215.0 per share. On average, they have given the company a rating of buy. At today's prices, JNJ is trading -9.82% away from its average analyst target price of $175.48 per share.
Over the last year, JNJ shares have gone down by -10.0%, which represents a difference of -27.0% when compared to the S&P 500. The stock's 52 week high is $181.04 per share and its 52 week low is $144.95. Although Johnson & Johnson's average free cash flow over the last 6 years has been $19.25 Billion, they have been decreasing at an average rate of -1.2%. For this reason, investors may continue to shun the stock.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 21,194,000 | 4,009,000 | 17,185,000 | -13.02 |
| 2022 | 23,410,000 | 3,652,000 | 19,758,000 | -2.13 |
| 2021 | 23,536,000 | 3,347,000 | 20,189,000 | 1.36 |
| 2020 | 23,416,000 | 3,498,000 | 19,918,000 | 0.0 |
| 2019 | 23,416,000 | 3,498,000 | 19,918,000 | 7.48 |
| 2018 | 22,201,000 | 3,670,000 | 18,531,000 |
